Medicine
Tadliq 20 mg/5 mL oral suspension
Tadliq 20 mg/5 mL oral suspension is a prescription medicine containing Tadalafil for oral use, marketed by CMP Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F): excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Tadalafil
- Brand
- Tadliq
- Strength
- 20 mg/5 mL
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 150 mL
- Marketing authorisation holder
- CMP Pharma
- Manufacturer
- CMP Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F): excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G04BE08 Tadalafil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 August 2022
- Identifiers
- RxCUI 2613563, 2613569DailyMed set ID 7a909b25-3772-403e-a5fe-e4a040293fb7NDC 46287-045Application NDA214522
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 150 mL in 1 bottle | 46287-045-15 | CMP Pharma | 30 August 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tadalafil
Clinical summary
Tadalafil is a phosphodiesterase 5 inhibitor indicated for the treatment of erectile dysfunction (ED) the signs and symptoms of benign prostatic hyperplasia (BPH), among other approved uses. It is available as tablets and oral suspension. MedsAcross supplies Tadalafil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TadalafilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cialis prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
- Adcirca (previously Tadalafil Lilly): European public assessment report (EPAR) · European Medicines Agency
- Cialis: European public assessment report (EPAR) · European Medicines Agency
Need Tadliq 20 mg/5 mL oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.